Back to Search
Start Over
3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors.
- Source :
-
Journal of medicinal chemistry [J Med Chem] 2016 May 12; Vol. 59 (9), pp. 4221-34. Date of Electronic Publication: 2015 Dec 14. - Publication Year :
- 2016
-
Abstract
- Bicyclic chiral scaffolds are privileged motifs in medicinal chemistry. Over the years, we have reported covalent bicyclic prolyl oligopeptidase inhibitors that were highly selective for POP over a number of homologous proteins. Herein, we wish to report the structure-based design and synthesis of a novel class of POP inhibitors based on hexahydroisoindoles. A docking study guided the selection of structures for synthesis. The stereochemistry, decoration, and position within the molecule of the bicyclic scaffolds were assessed virtually. Following the synthesis of the best candidates, in vitro assays revealed that one member of this chemical series was more active than any of our previous inhibitors with a Ki of 1.0 nM. Additional assays also showed that the scaffold of this potent inhibitor, in contrast to one of our previously reported chemical series, is highly metabolically stable, despite the foreseen potential sites of metabolism. Interestingly, computer docking calculations accurately predicted the optimal features of the inhibitors.
- Subjects :
- Humans
Molecular Docking Simulation
Molecular Structure
Prolyl Oligopeptidases
Stereoisomerism
Bridged Bicyclo Compounds chemistry
Carboxylic Acids chemistry
Isoindoles chemistry
Isoindoles pharmacology
Protease Inhibitors chemistry
Protease Inhibitors pharmacology
Serine Endopeptidases drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1520-4804
- Volume :
- 59
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Journal of medicinal chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 26619267
- Full Text :
- https://doi.org/10.1021/acs.jmedchem.5b01296